ArticleJournal of clinical medicine2022

Efficacy and Safety of Rituximab in Autoimmune Disease-Associated Interstitial Lung Disease: A Prospective Cohort Study.

Natalia Mena-Vázquez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.